# Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke

> **NCT00933868** · PHASE2,PHASE3 · COMPLETED · sponsor: **Relox Medical, LLC** · enrollment: 81 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Magnesium Chloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00933868
- **Lead sponsor:** Relox Medical, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-07
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2012-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00933868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00933868, "Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00933868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*